Free Trial

Verve Therapeutics (VERV) Earnings Date, Estimates & Call Transcripts

Verve Therapeutics logo
$4.40 +0.17 (+3.89%)
As of 11:13 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Verve Therapeutics Earnings Summary

Verve Therapeutics posted Q1 2025 earnings on May 14, 2025, reporting an EPS of -$0.35, which beat analysts' consensus estimates of -$0.71 by $0.36. Quarterly revenue was reported to be $32.98 million, above the consensus estimate of $7.13 million. With a trailing EPS of -$2.11, Verve Therapeutics' earnings are expected to decrease next year, from ($2.49) to ($2.83) per share.

Upcoming Q2
Earnings Date
Aug. 14Before Market OpensEstimated
Consensus EPS
(May. 14)
-$0.71
Actual EPS
(May. 14)
-$0.35 Beat By $0.36
Actual Revenue
(May. 14)
$32.98M

Q1 2025 Earnings Resources

VERV Upcoming Earnings

Verve Therapeutics' next earnings date is estimated for Thursday, August 14, 2025, based on past reporting schedules.

Get Verve Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Verve Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

VERV Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

VERV Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Verve Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20252-$0.66-$0.60-$0.63
Q2 20252-$0.63-$0.63-$0.63
Q3 20252-$0.73-$0.65-$0.69
Q4 20252-$0.73-$0.66-$0.70
FY 2025 8 -$2.75 -$2.54 -$2.65
Q1 20262-$0.75-$0.61-$0.68
Q2 20262-$0.73-$0.66-$0.70
Q3 20262-$0.74-$0.68-$0.71
Q4 20262-$0.75-$0.70-$0.73

Verve Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/14/2025
(Estimated)
--------
5/14/2025Q1 2025-$0.71-$0.35+$0.36-$0.35$7.13M$32.98M
2/27/2025Q4 2024-$0.72-$0.58+$0.14-$0.58$3.94M$13.08M
11/5/2024Q3 2024-$0.70-$0.59+$0.11-$0.59$2.75M$6.87M
8/8/2024Q2 2024-$0.68-$0.59+$0.09-$0.59$2.40M$6.70M
5/8/2024Q1 2024-$0.70-$0.59+$0.11-$0.59$2.11M$5.70M
2/27/2024Q4 2023-$0.83-$0.69+$0.14-$0.69$3.95M$5.14M
11/7/2023Q3 2023-$0.90-$0.72+$0.18-$0.72$0.96M$3.10M
8/10/2023Q2 2023-$0.90-$0.87+$0.03-$0.87$0.67M$2.10M

Verve Therapeutics Earnings - Frequently Asked Questions

Verve Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 14th, 2025 based off last year's report dates. Learn more on VERV's earnings history.

In the previous quarter, Verve Therapeutics (NASDAQ:VERV) reported ($0.35) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.71) by $0.36. Learn more on analysts' earnings estimate vs. VERV's actual earnings.

Verve Therapeutics (NASDAQ:VERV) has a recorded annual revenue of $59.61 million.

Verve Therapeutics (NASDAQ:VERV) has a recorded net income of -$200.07 million. VERV has generated -$2.11 earnings per share over the last four quarters.

Verve Therapeutics's earnings are expected to decrease from ($2.49) per share to ($2.83) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:VERV) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners